Biotechnology — How Molecular Profiling Works

Today’s health care industry is experiencing a paradigm shift that is driving a tighter integration of genomic analysis modalities in patient care decisions. From disease diagnostics and prognostics to carrier testing and clinical trial enrollment, physicians and oncologists are ordering a growing number of genetic tests for an expanding menu of applications.

Within the last decade, Molecular Profiling has become a gold standard of care for many types of cancer. It’s more robust in its accuracy as the technology has advanced dramatically. Innovative researchers in biotechnology are actively working to fulfill the promise of exactitude medicine through exceptionally transformative platforms to help patients with cancer and multiple complex disease biomarkers.

Biomarkers are a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

How is Molecular Profiling used?

Molecular Profiling is used in the following test that can detect various types of cancerous cells growing in the body: